Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

Critical review on non-myeloablative stem cell transplantation (NST).

Anagnostopoulos A, Giralt S.

Crit Rev Oncol Hematol. 2002 Nov;44(2):175-90. Review.

PMID:
12413634
2.

Update on non-myeloablative stem cell transplantation for hematologic malignancies.

Giralt S.

Int J Hematol. 2002 Aug;76 Suppl 1:368-75. Review.

PMID:
12430884
3.

Update on non-myeloablative stem cell transplantation for hematologic malignancies.

Giralt S.

Int J Hematol. 2002 Aug;76 Suppl 1:176-83. Review.

PMID:
12430850
6.

Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy.

Levine JE, Uberti JP, Ayash L, Reynolds C, Ferrara JL, Silver SM, Braun T, Yanik G, Hutchinson R, Ratanatharathorn V.

Biol Blood Marrow Transplant. 2003 Mar;9(3):189-97.

PMID:
12652470
7.

Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.

Resnick IB, Shapira MY, Slavin S.

Transpl Immunol. 2005 Aug;14(3-4):207-19. Epub 2005 Apr 26. Review.

PMID:
15982565
8.

Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.

Slavin S, Aker M, Shapira MY, Resnick I, Bitan M, Or R.

Clin Transpl. 2003:275-82. Review.

PMID:
15387119
9.

Non-myeloablative stem cell transplantation and donor lymphocyte infusion for the treatment of cancer and life-threatening non-malignant disorders.

Slavin S, Nagler A, Aker M, Shapira MY, Cividalli G, Or R.

Rev Clin Exp Hematol. 2001 Jun;5(2):135-46. Review.

PMID:
11486652
10.

Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen.

Morecki S, Gelfand Y, Nagler A, Or R, Naparstek E, Varadi G, Engelhard D, Akerstein A, Slavin S.

Bone Marrow Transplant. 2001 Aug;28(3):243-9.

11.

Allogeneic transplantation using non-myeloablative transplant regimens.

Battiwalla M, Barrett J.

Best Pract Res Clin Haematol. 2001 Dec;14(4):701-22. Review.

PMID:
11924917
12.

[Non-myeloablative stem cell transplant].

Shoji N, Mineishi S.

Gan To Kagaku Ryoho. 2000 Jun;27(6):795-800. Review. Japanese.

PMID:
10897204
13.

Non-myeloablative stem cell transplantation for the treatment of cancer and life-threatening non-malignant disorders; past accomplishments and future goals.

Slavin S, Aker M, Shapira MY, Panigrahi S, Gabriel C, Or R.

Transfus Apher Sci. 2002 Oct;27(2):159-66. Review.

PMID:
12350051
14.

Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed.

Fung HC, Cohen S, Rodriguez R, Smith D, Krishnan A, Somlo G, Sahebi F, Senitzer D, O'Donnell MR, Stein A, Snyder DS, Spielberger R, Bhatia R, Falk P, Molina A, Nademanee A, Parker P, Kogut N, Popplewell L, Vora N, Margolin K, Forman SJ.

Biol Blood Marrow Transplant. 2003 Oct;9(10):649-56.

15.

[Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].

Michallet M, Dhedin N, Michallet AS.

Bull Cancer. 2001 Sep;88(9):908-26. Review. French.

16.
17.

Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation.

Champlin R, Khouri I, Anderlini P, Gajewski J, Kornblau S, Molldrem J, Shimoni A, Ueno N, Giralt S.

Bone Marrow Transplant. 2001 May;27 Suppl 2:S13-22. Review.

18.

Current indications for reduced-intensity allogeneic stem cell transplantation.

Haddad N, Rowe JM.

Best Pract Res Clin Haematol. 2004 Sep;17(3):377-86. Review.

PMID:
15498710
19.

Nonmyeloablative stem cell transplantation: lessons from the first decade of clinical experience.

Shimoni A, Nagler A.

Curr Hematol Rep. 2004 Jul;3(4):242-8. Review.

PMID:
15217553
20.

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.

Bethge WA, Faul C, Bornhäuser M, Stuhler G, Beelen DW, Lang P, Stelljes M, Vogel W, Hägele M, Handgretinger R, Kanz L.

Blood Cells Mol Dis. 2008 Jan-Feb;40(1):13-9. Epub 2007 Sep 14.

PMID:
17869547

Supplemental Content

Support Center